Earnings History Data for Athersys, Inc. (ATHX) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Athersys, Inc.

Athersys, Inc., a late stage biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused primarily on treating critical care indications neurological conditions, cardiovascular diseases, inflammatory and immune disorders, pulmonary and other conditions. The company's lead platform product is MultiStem cell therapy, an `off the shelf` allogeneic stem cell product currently in Phase 3 clinical development for treating ischemic stroke. Based on promising Phase 2 results, this program has received Fast Track and RMAT (equivalent to Breakthrough Therapy for regenerative medicine treatments) designations from the FDA, as well as similar designations in Japan. The company also has an ongoing Phase II clinical study for treating patients with acute myocardial infarction; a planned Phase II for trauma (supported by the DOD).

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
16-08-2023	AH		ATHX	Athersys, Inc.	8.71	-0.62	0.00	-2.25	Athersys GAAP EPS of -$0.62 misses by $0.33, revenue of $0.05M [8/16/2023 5:23 PM]	0.39	-0.03 (-7.14%)	0.43	0.01 (2.38%)	0.34 - 6.00	572,807	850,000	7,077
Athersys GAAP EPS of -$0.62 misses by $0.33, revenue of $0.05M [8/16/2023 5:23 PM]
14-11-2022	PM	4:15 PM ET (Nov 10)	ATHX	Athersys, Inc.	6.93	-1.15	-1.96	-1.75	Athersys GAAP EPS of -$1.15 beats by $0.89, revenue of $0.07M [11/15/2022 8:16 AM]	0.58	-0.11 (-16.22%)	0.68	-0.01 (-1.86%)	0.52 - 33.50	1,780,946	2,220,000	56,523
Athersys GAAP EPS of -$1.15 beats by $0.89, revenue of $0.07M [11/15/2022 8:16 AM] Athersys GAAP EPS of -$1.15 beats by $0.81, revenue of $0.1M [11/15/2022 8:39 AM] Athersys to Present at Challenges and Opportunities for Mesenchymal Stem Cells Digital Conference and Participate in A.G.P.s Biotech Conference [Nov-11-22 08:30AM] Athersys Reports Third Quarter 2022 Financial Results and Provides Business Update [Nov-15-22 08:00AM]
11-08-2022	AH	4:05 PM ET (Aug 11)	ATHX	Athersys, Inc.	51.63	-0.09	-0.07	-0.10	Athersys GAAP EPS of -$0.09 in-line, revenue of $2.32M [8/11/2022 4:32 PM]	0.2573	-0.02 (-8.63%)	0.28	0.0 (-1.46%)	0.17 - 1.81	5,671,304	16,770,000	1,309,115
Athersys GAAP EPS of -$0.09 in-line, revenue of $2.32M [8/11/2022 4:32 PM] Athersys Reports Second Quarter 2022 Financial Results and Provides Business Update [Aug-11-22 04:17PM] Athersys (ATHX) Q2 2022 Earnings Call Transcript [Aug-11-22 10:30PM] Athersys needs to raise capital to survive, CEO says [Aug-11-22 07:51PM]
06-05-2022	PM	7:00 AM ET (May 6)	ATHX	Athersys, Inc.	140.78	-0.09	0.00	-0.13	Athersys GAAP EPS of -$0.09 in-line, revenue of $2.91M beats by $1.53M [5/6/2022 8:09 AM]	0.6251	0.07 (12.17%)	0.63	0.0 (0.00%)	0.46 - 1.81	9,204,144	3,110,000	2,082
Athersys Q1 2022 Earnings Preview [5/5/2022 12:14 PM] Athersys GAAP EPS of -$0.09 in-line, revenue of $2.91M beats by $1.53M [5/6/2022 8:09 AM] Athersys Reports First Quarter 2022 Results [May-06-22 08:00AM]
15-03-2022	AH	4:05 PM ET (Mar 15)	ATHX	Athersys	188.00	-0.09	-0.07	0.00	Athersys GAAP EPS of -$0.09, revenue of $0.72M [3/15/2022 4:07 PM]	0.6928	0.0 (0.49%)	0.67	-0.02 (-2.81%)	0.67 - 1.98	1,614,646	1,363,988	12,544
AnaptysBio's (ANAB) Acne Study on Imsidolimab Fails to Meet Goal [Mar-15-22 11:35AM] Athersys Reports Fourth Quarter and Full Year 2021 Financial Results and Business Highlights [Mar-15-22 04:05PM] Epizyme (EPZM) Down More Than 50% in Past 3 Months: Here's Why [Mar-16-22 12:00PM] Athersys may be close to commercializing stem cell therapy in Japan, new CEO says [Mar-16-22 06:23PM]
15-11-2021	AH	4:05 PM ET (Nov 15)	ATHX	Athersys, Inc.	289.61	-0.07	-0.08	-0.11	Athersys EPS beats by $0.04 [11/15/2021 4:10 PM]	1.25	0.10 (8.70%)	1.18	0.03 (2.61%)	1.10 - 3.03	2,701,199	1,390,000	61,879
Athersys EPS beats by $0.04 [11/15/2021 4:10 PM] The Daily Biotech Pulse: J&J To Spin-off Consumer Health Business, AstraZeneca Earnings, Embattled Emergent To Buy Back Shares [Nov-12-21 07:40AM] Athersys Reports Updates on Timing for Japan ARDS and Stroke Programs From Healios K.K. [Nov-12-21 06:00AM] Athersys Reports Third Quarter 2021 Results and Provides Corporate Update [Nov-15-21 04:05PM] Athersys (ATHX) Q3 2021 Earnings Call Transcript [Nov-16-21 01:30AM]
09-08-2021	AH	4:05 PM ET (Aug 9)	ATHX	Athersys, Inc.	348.43	-0.10	-0.08	-0.10	Athersys EPS beats by $0.02 [8/9/2021 4:15 PM]	1.61	0.08 (5.23%)	1.59	0.06 (3.92%)	1.35 - 3.03	3,162,564	1,650,000	76,047
Athersys EPS beats by $0.02 [8/9/2021 4:15 PM] Athersys partner HEALIOS completes enrollment in phase 2/3 ischemic stroke trial [8/10/2021 9:24 AM] Athersys Stock Rises on Positive Results for Stem Cell Therapy [Aug-06-21 06:12AM] Athersys Partner HEALIOS K.K. Announces Positive Topline Results of MultiStem for Acute Respiratory Distress Syndrome in the ONE-BRIDGE Study [Aug-06-21 06:00AM] Athersys Reports Second Quarter 2021 Results [Aug-09-21 04:05PM] Athersys (ATHX) Q2 2021 Earnings Call Transcript [Aug-10-21 01:01AM] Athersys Partner HEALIOS K.K. Completes Enrollment in the TREASURE Study of MultiStem Treatment for Ischemic Stroke [Aug-10-21 09:17AM]
06-05-2021	AH	4:05 PM ET (May 6)	ATHX	Athersys, Inc.	344.39	-0.13	-0.08	-0.10	Athersys EPS misses by $0.02, misses on revenue [5/6/2021 4:09 PM]	1.54	-0.02 (-1.28%)	1.55	-0.01 (-0.64%)	1.51 - 3.39	1,893,783	1,740,000	4,747
Athersys EPS misses by $0.02, misses on revenue [5/6/2021 4:09 PM] Athersys Reports First Quarter 2021 Results [May-06-21 04:05PM] Athersys (ATHX) Q1 2021 Earnings Call Transcript [May-07-21 01:01AM]
25-03-2021	AH	4:05 PM ET (Mar 25)	ATHX	Athersys, Inc.	345.97	-0.11	-0.09	-0.06	Athersys EPS beats by $0.32, beats on revenue [3/25/2021 4:06 PM]	1.70	-0.04 (-2.59%)	1.60	-0.14 (-8.05%)	1.53 - 4.38	4,103,874	3,180,000	99,424
Athersys EPS beats by $0.32, beats on revenue [3/25/2021 4:06 PM] Athersys Announces Financial Results for Fourth Quarter and Full Year 2020 [Mar-25-21 04:05PM] Athersys (ATHX) Q4 2020 Earnings Call Transcript [Mar-25-21 09:00PM]
09-11-2020	AH	4:00 PM ET (Nov 9)	ATHX	Athersys, Inc.	357.30	-0.11	-0.08	-0.08	Athersys EPS misses by $0.01, misses on revenue [11/9/2020 4:08 PM]	1.94	0.12 (6.28%)	1.69	-0.14 (-7.65%)	1.13 - 4.38	1,782,988	1,458,216	5,783

10-08-2020	AH	4:05 PM ET (Aug 10)	ATHX	Athersys, Inc.	511.64	-0.10	-0.08	-0.06	Athersys EPS misses by $0.02 [8/10/2020 4:03 PM]	2.37	-0.22 (-8.69%)	2.40	-0.19 (-7.34%)	1.13 - 4.38	2,250,628	2,407,826	47,058